The Los Angeles Chargers today elevated cornerback Eli Apple and outside linebacker Caleb Murphy from ... In corresponding moves, Los Angeles placed running back Gus Edwards and cornerback Asante ...

Memoirs Of Sir Edwin Landseer A Sketch Of The Life Of The Artist, Illustrated With Reproductuions Of Twenty-Four Of His Most Popular Works. Being a New Edition of "The Early Works of Sir Edwin ...

Mariah Carey has released her annual video officially announcing the start of the Christmas season. This year, the singer dressed as Morticia Addams for the festive clip, which begins in eery ...

Eli Lilly reported third-quarter results before the market opened on Wednesday. Management missed Wall Street estimates and lowered earnings guidance for 2024. Sales of Zepbound and Mounjaro ...

You can let your worst fears go. Missouri football coach Eli Drinkwitz, during the SEC Football Coaches Teleconference on Wednesday, said he expects starting quarterback Brady Cook to return from ...

Eli Lilly's (LLY.N), opens new tab high profile weight-loss and diabetes drugs fell short of Wall Street sales estimates on Wednesday as supplies sat in warehouses, a 180-degree turn for the ...

AJ Mast / Bloomberg via Getty Images Eli Lilly (LLY) shares tumbled 12% at the opening bell Wednesday after its third-quarter results fell well short of analysts' estimates and it lowered its full ...

Drug maker Eli Lilly’s share price plunged Wednesday morning after the company reported worse third-quarter results than expected, especially in its weight-loss drug division, registering a rare ...

Shares of Eli Lilly and Co. slumped toward their biggest selloff in more than three years on Wednesday, after the drugmaker reported third-quarter results that missed expectations, due to big ...

Eli Lilly reported Q3 revenue and earnings that fell short of analysts' expectations. Mounjaro and Zepbound faced challenges as U.S. wholesalers reduced inventories of the drugs. The bull case for ...

Eli Lilly has dropped (PDF) the lead candidate from its $2.4 billion takeover of Dice Therapeutics, shifting the focus of its oral IL-17 psoriasis program to a follow-up molecule. Lilly kicked DC ...